Movement disorders are common manifestations in autoimmune-mediated encephalitis. This group of diseases is suspected to be triggered by infection or neoplasm. Certain phenotypes correlate with specific autoantibody-related neurological disorders, such as orofacial-lingual dyskinesia with N-methyl-D-aspartate receptor encephalitis and faciobrachial dystonic seizures with leucine-rich glioma-inactivated protein 1 encephalitis. Early diagnosis and treatment, especially for autoantibodies targeting neuronal surface antigens, can improve prognosis. In contrast, the presence of autoantibodies against intracellular neuronal agents warrants screening for underlying malignancy. However, early clinical diagnosis is challenging because these diseases can be misdiagnosed. In this article, we review the distinctive clinical phenotypes, magnetic resonance imaging findings, and current treatment options for autoimmune-mediated encephalitis.
Citations
Citations to this article as recorded by
A case of corticobasal syndrome possibly associated with anti-Yo antibodies Efthalia Angelopoulou, Vasilios C. Constantinides, Evangelos Koumasopoulos, Evangelia Stanitsa, Efstratios-Stylianos Pyrgelis, Andreas Kyrozis, Elisabeth Kapaki, Leonidas Stefanis, Sokratis G. Papageorgiou Current Medical Research and Opinion.2024; 40(10): 1737. CrossRef
Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort Shreyashi Jha, Netravathi M, Vikram Venkappayya Holla, Nitish Kamble, Anita Mahadevan, Pramod Kumar Pal Annals of Movement Disorders.2024; 7(3): 189. CrossRef
The treatment of delirium or psychosis in patients with Parkinson’s disease (PD) can be complicated by the limited number of pharmacological agents that can be used in this population. Typical and atypical antipsychotics are contraindicated, as they can worsen motor symptoms. The treatment of acute delirium is even more complicated in the hospital setting, as many medications deemed safer in this population are only available in oral form. We present a case of acute delirium in a patient with PD, likely precipitated by a polypharmacy interaction of new medications, that was successfully managed by transferring the patient to the intensive care unit and administering dexmedetomidine for 72 hours.
Citations
Citations to this article as recorded by
Drug-induced psychotic syndrome Jana Hroudová Klinická farmakologie a farmacie.2024; 38(2): 83. CrossRef
Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson’s Disease: A Comprehensive Review Kenneth R. Dalton, Charles J. Kidd, Nawaz Hack Journal of Clinical Medicine.2023; 12(3): 1074. CrossRef
Fountain of youth—Targeting autophagy in aging Lea Danics, Anna Anoir Abbas, Balázs Kis, Karolina Pircs Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
Effect of dexmedetomidine on postoperative delirium in patients undergoing brain tumour resections: study protocol of a randomised controlled trial Dexiang Wang, Ruowen Li, Shu Li, Juan Wang, Min Zeng, Jia Dong, Xiaoyuan Liu, Nan Lin, Yuming Peng BMJ Open.2021; 11(11): e051584. CrossRef
Spinal myoclonus is a sudden, brief, and involuntary movement of segmental or propriospinal muscle groups. Spinal myoclonus has occasionally been reported in patients undergoing opioid therapy, but the pathophysiology of opioid-induced myoclonus has not been elucidated yet. Here, we present two patients with spinal segmental myoclonus secondary to ischemic and radiation myelopathy. Conventional medications did not help treat persistent myoclonus in both legs. Continuous intrathecal morphine infusion was implanted for pain control in one patient, which relieved spinal myoclonus entirely. This experience led to the application of this method with a second patient, leading to the same gratifying result. Spinal myoclonus reemerged as soon as the morphine pumps were off, which confirmed the therapeutic role of opioids. In contrast to the opioid-induced myoclonus, these cases show a benefit of opioids on spinal myoclonus, which could be explained by synaptic reorganization after pathologic insults in the spinal cord.
Citations
Citations to this article as recorded by
Spinal segmental myoclonus following spinal surgery Shrikant Pande, Kokcher Ang, May Win Myat, Shermyn Neo, Sivashankar Subramaniam British Journal of Neurosurgery.2023; 37(3): 393. CrossRef
Movement Disorders Associated With Radiotherapy and Surgical Procedures Bharath Kumar Surisetti, Shweta Prasad, Vikram Venkappayya Holla, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal Journal of Movement Disorders.2023; 16(1): 42. CrossRef
Myoclonus: An Electrophysiological Diagnosis Shabbir Hussain I. Merchant, Felipe Vial‐Undurraga, Giorgio Leodori, Jay A. van Gerpen, Mark Hallett Movement Disorders Clinical Practice.2020; 7(5): 489. CrossRef
Post-stroke movement disorders are uncommon, but comprise an important part of secondary movement disorders. These exert variable and heterogeneous clinical courses according to the stroke lesion and its temporal relationships. Moreover, the predominant stroke symptoms hinder a proper diagnosis in clinical practice. This article describes the etiology, treatment options and prognosis of post-stroke movement disorders.
Citations
Citations to this article as recorded by
Post-stroke movement disorders disappearance: a report of disappearance of tardive dyskinesia after stroke and a literature review Min Seung Kim, InJa Shin, Don Gueu Park, Jung han Yoon Acta Neurologica Belgica.2023; 123(5): 2005. CrossRef
Monochorea after acute contralateral pontine infarction: A case report Yun Su Hwang, Byoung-Soo Shin, Han Uk Ryu, Hyun Goo Kang Medicine.2023; 102(3): e32660. CrossRef
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study Roberta Bovenzi, Matteo Conti, Rocco Cerroni, Mariangela Pierantozzi, Alessandro Stefani, Antonio Pisani, Nicola Biagio Mercuri, Tommaso Schirinzi Neurological Sciences.2022; 43(1): 387. CrossRef
Parkinsonism and ataxia Giulia Franco, Giulia Lazzeri, Alessio Di Fonzo Journal of the Neurological Sciences.2022; 433: 120020. CrossRef
Movement Disorders Associated With Cerebral Artery Stenosis: A Nationwide Study Kye Won Park, Nari Choi, Eungseok Oh, Chul Hyoung Lyoo, Min Seok Baek, Han-Joon Kim, Dalla Yoo, Jee-Young Lee, Ji-Hyun Choi, Jae Hyeok Lee, Seong-Beom Koh, Young Hee Sung, Jin Whan Cho, Hui-Jun Yang, Jinse Park, Hae-Won Shin, Tae-Beom Ahn, Ho-Sung Ryu, So Frontiers in Neurology.2022;[Epub] CrossRef
Hemibalismo y hemicorea secundarios a un ataque cerebrovascular isquémico insular, una presentación inusual: reporte de caso Carlos Martínez-Rubio, Hellen Kreinter-Rosenbaum, Habib Moutran-Barroso Neurología Argentina.2020; 12(3): 207. CrossRef
Hemiballismus in subcortical lacunar infarcts ChinyeluUchenna Ufoaroh, OvercomerNnaemeka Agah, Nnamdi Morah, ErnestNdukaife Anyabolu Nigerian Journal of Medicine.2020; 29(3): 527. CrossRef
COVID-19 and stroke: Red flags for secondary movement disorders? Daniella Balduino Victorino, Marcia Guimarães-Marques, Mariana Nejm, Fulvio Alexandre Scorza, Carla Alessandra Scorza eNeurologicalSci.2020; 21: 100289. CrossRef
Post-stroke restless arm syndrome mimicking hemichorea–hemiballism Ha-yom Kim, Moon-Ho Park, Do-Young Kwon Acta Neurologica Belgica.2017; 117(3): 791. CrossRef
Vascular Pathology Causing Late Onset Generalized Chorea: A Clinico‐Pathological Case Report Paula Salgado, Ricardo Taipa, Joana Domingos, Daniel Dias, Manuel Melo Pires, Marina Magalhães Movement Disorders Clinical Practice.2017; 4(6): 819. CrossRef
Objective
The purpose of the present study was to investigate cardiovascular autonomic dysfunction in patients with Parkinson’s disease (PD) with mild to severe stages of motor symptoms and to compare cardiovascular autonomic dysfunction between drug-naïve and dopaminergic drug-treated groups.
Methods
This study included 188 PD patients and 25 age-matched healthy controls who underwent head-up tilt-testing, 24-h ambulatory blood pressure (BP) monitoring and 24-h Holter monitoring. Autonomic function test results were evaluated among groups categorized by motor symptom severities (mild vs. moderate vs. severe) and treatment (drug-naïve or dopaminergic drug treatment).
Results
Orthostatic hypotension and supine hypertension were more frequent in patients with PD than in healthy controls. The frequencies of orthostatic hypotension, supine hypertension, nocturnal hypertension and non-dipping were not different among groups. Additionally, no significant differences were detected in supine BP, orthostatic BP change, nighttime BP, nocturnal BP dipping, or heart rate variabilities among groups.
Conclusions
Cardiovascular autonomic dysfunction is not confined to moderate to severe PD patients, and starts early in the course of the disease in a high proportion of PD patients. In addition, dopaminergic drug treatments do not affect cardiovascular autonomic function.
Citations
Citations to this article as recorded by
Reverse nocturnal blood pressure dipping in Parkinson's disease is affected by physical activity but not sleep disturbances Kazushi Deguchi, Kazuyo Ikeda, Tetsuo Touge, Asahiro Morishita, Hideki Kobara, Tsutomu Masaki Neurology and Clinical Neuroscience.2025; 13(1): 22. CrossRef
Holter monitoring: Understanding its indications, contraindications, and clinical relevance Soumen Jana, Nandita Chakraborty The Journal of Community Health Management.2025; 11(4): 182. CrossRef
Exercise Strategies for Parkinson Disease Management Spencer Ingoglia, Barbara Sue Graves Strength & Conditioning Journal.2025;[Epub] CrossRef
Parkinson's disease patients with absence of normal dipping status were more vulnerable to cognitive impairment from the early stages Lanlan Chen, Li Jiang, Chenxin Wang, Tingting Qiao, Cancan Ma, Yingzhu Chen, Chunfeng Liu, Xin Wang, Yao Xu Parkinsonism & Related Disorders.2024; 121: 106013. CrossRef
Associations of sleep-related variables with reverse dipping patterns of blood pressure in α-synucleinopathies Yunchuang Sun, Luhua Wei, Fan Li, Chen Ling, Fei Zhai, Yunfeng Lv, Hong Zhou, Cheng Zhang, Jing Ma, Jing Chen, Wei Sun, Zhaoxia Wang Parkinsonism & Related Disorders.2024; 121: 106046. CrossRef
Electrocardiographic approach strategies in patients with Parkinson disease treated with deep brain stimulation Carlos Rafael Sierra-Fernández, Luis Rodrigo Garnica-Geronimo, Alejandra Huipe-Dimas, Jorge A. Ortega-Hernandez, María Alejandra Ruiz-Mafud, Amin Cervantes-Arriaga, Ana Jimena Hernández-Medrano, Mayela Rodríguez-Violante Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef
The correlation of orthostatic hypotension in Parkinson disease with the disease course and severity and its impact on quality of life Yuanyuan Meng, Tianping Tang, Juanjuan Wang, Kun Yu Medicine.2024; 103(19): e38169. CrossRef
Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study Shubhra Acharya, Andrew I. Lumley, Yvan Devaux, Muhammad Ali, Nancy E. Ramia, Giuseppe Arena, Rudi Balling, Michele Bassis, Regina Becker, Ibrahim Boussaad, Piotr Gawron, Soumyabrata Ghosh, Enrico Glaab, Elisa Gómez De Lope, Valentin Groues, Anne Grünewal BMC Neuroscience.2024;[Epub] CrossRef
Autonomic control of heart and vessels in patients with very early stage of Parkinson disease J Oleksakova, M Javorka, B Czippelova, N Mazgutova, M Grofik, L Babalova, P Skacik, E Kurca Physiological Measurement.2023; 44(5): 054002. CrossRef
Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy Daniel H. Lench, Travis H. Turner, Colin McLeod, Heather A. Boger, Lilia Lovera, Lisa Heidelberg, Jordan Elm, Anh Phan, Bashar W. Badran, Vanessa K. Hinson Frontiers in Neurology.2023;[Epub] CrossRef
Neurogenic Supine Hypertension and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease Sunil Kapoor, Alvee Saluja, Shubha Laxmi Margekar, Mayank Agarwal, Sunita Mondal, Rajinder K. Dhamija Annals of Indian Academy of Neurology.2023; 26(1): 33. CrossRef
Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study Mehmet Balal, Meltem Demirkiran, Saime Paydas, Seyed-Mohammad Fereshtehnejad Parkinson's Disease.2022; 2022: 1. CrossRef
Cardiovascular Autonomic Dysfunction in Idiopathic Parkinson's Disease Sahil Mehta Annals of Indian Academy of Neurology.2022; 25(5): 803. CrossRef
Spectrum of Cardiovascular Autonomic Dysfunction and 24-hour Blood Pressure Variability in Idiopathic Parkinson's Disease Ivy Sebastian, Mahesh P. Kate, Himani Khatter, Bharat Singh, Jeyaraj D. Pandian Annals of Indian Academy of Neurology.2022; 25(5): 902. CrossRef
Blood Pressure Patterns in Patients with Parkinson’s Disease: A Systematic Review Delia Tulbă, Liviu Cozma, Paul Bălănescu, Adrian Buzea, Cristian Băicuș, Bogdan Ovidiu Popescu Journal of Personalized Medicine.2021; 11(2): 129. CrossRef
Inverted circadian variation of arterial pressure in a geriatric patient: an indicator of autonomic dysfunction Siddhartha Lieten, Aziz Debain, Bert Bravenboer, Tony Mets BMC Geriatrics.2021;[Epub] CrossRef
Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation Beatrice De Maria, Laura Adelaide Dalla Vecchia, Alberto Porta, Maria Teresa La Rovere Herzschrittmachertherapie + Elektrophysiologie.2021; 32(3): 315. CrossRef
Heart Rate Variability Analyses in Parkinson’s Disease: A Systematic Review and Meta-Analysis Konstantin G. Heimrich, Thomas Lehmann, Peter Schlattmann, Tino Prell Brain Sciences.2021; 11(8): 959. CrossRef
Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis Feifei Mu, Qian Jiao, Xixun Du, Hong Jiang Neurological Sciences.2020; 41(6): 1419. CrossRef
Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn Geriatrics & Gerontology International.2020; 20(5): 443. CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists Ji-Hyun Choi, Jong-Min Kim, Hee Kyung Yang, Hyo-Jung Lee, Cheol Min Shin, Seong Jin Jeong, Won-Seok Kim, Ji Won Han, In-Young Yoon, Yoo Sung Song, Yun Jung Bae Journal of Korean Medical Science.2020;[Epub] CrossRef
Autonomic Dysfunction in Parkinson's Disease Ronald F. Pfeiffer Neurotherapeutics.2020; 17(4): 1464. CrossRef
Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease Hae-Won Shin, Seok Jong Chung, Sangwon Lee, Jungho Cha, Young H. Sohn, Mijin Yun, Phil Hyu Lee Clinical Nuclear Medicine.2020; 45(8): e342. CrossRef
Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease – the SFC BP multicentre study in China Shi-Wu Chen, Yu-Kai Wang, Rong-Hua Dou, Xin-Yi Xie, Yong-Bo Hu, Nan Ding, Guo-Hua Zhang, Hai-Fang Jing, Wei-Dong Zhao, Yan Xue, Yan Li, Gang Wang Journal of Hypertension.2020; 38(11): 2270. CrossRef
Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors Lixia Li, Peng Guo, Duyu Ding, Tenghong Lian, Lijun Zuo, Fenghe Du, Wei Zhang Neurological Research.2019; 41(8): 734. CrossRef
Neurogenic Orthostatic Hypotension in
Parkinson Disease: A Primer Jeremy K. Cutsforth-Gregory, Phillip A. Low Neurology and Therapy.2019; 8(2): 307. CrossRef
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease Claudia Carricarte Naranjo, Connie Marras, Naomi P. Visanji, David J. Cornforth, Lazaro Sanchez-Rodriguez, Birgitt Schüle, Samuel M. Goldman, Mario Estévez, Phyllis K. Stein, Anthony E. Lang, Herbert F. Jelinek, Andrés Machado Clinical Autonomic Research.2019; 29(6): 603. CrossRef
Considerations before initiating therapy in Parkinsonism: basing on the quality of life Shu-Jin He, Zhen-Yang Liu, Yu-Jie Yang, Cong Shen, Yu-Jie Du, Xin-Yue Zhou, Jue Zhao, Yi-Min Sun, Ke Yang, Jian-Jun Wu, Feng-Tao Liu, Jian Wang Journal of Neurology.2019; 266(12): 3119. CrossRef
Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden British Journal of Clinical Pharmacology.2018; 84(11): 2551. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism Joong-Seok Kim, Dong-Woo Ryu, Ju-Hee Oh, Yang-Hyun Lee, Sung-Jin Park, Kipyung Jeon, Jong-Yun Lee, Seong Hee Ho, Jungmin So, Jin Hee Im, Kwang-Soo Lee Journal of Clinical Neurology.2017; 13(1): 15. CrossRef
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype? J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee European Journal of Neurology.2017; 24(2): 349. CrossRef
The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism Younsoo Kim, Jin Myoung Seok, Jongkyu Park, Kun-Hyun Kim, Ju-Hong Min, Jin Whan Cho, Suyeon Park, Hyun-jin Kim, Byoung Joon Kim, Jinyoung Youn, Pedro Gonzalez-Alegre PLOS ONE.2017; 12(7): e0180744. CrossRef
Cardiac sympathetic denervation predicts PD in at-risk individuals David S. Goldstein, Courtney Holmes, Grisel J. Lopez, Tianxia Wu, Yehonatan Sharabi Parkinsonism & Related Disorders.2017;[Epub] CrossRef
Loss of cutaneous large and small fibers in naive and
l
-dopa–treated PD patients
Maria Nolano, Vincenzo Provitera, Fiore Manganelli, Rosa Iodice, Annamaria Stancanelli, Giuseppe Caporaso, Annamaria Saltalamacchia, Francesca Califano, Bernardo Lanzillo, Marina Picillo, Paolo Barone, Lucio Santoro Neurology.2017; 89(8): 776. CrossRef
Arterial Stiffness and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Hyun-Seok Choi, Kwang-Soo Lee Neurodegenerative Diseases.2017; 17(2-3): 89. CrossRef
Prevalence and Prescribed Treatments of Orthostatic Hypotension in Institutionalized Patients with Parkinson’s Disease ALAJ Hommel, MJ Faber, NJ Weerkamp, JG van Dijk, BR Bloem, RT Koopmans Journal of Parkinson’s Disease.2016; 6(4): 805. CrossRef
Objective Stem cell treatment is a well-recognized experimental treatment among patients with Parkinson’s disease (PD), for which there are high expectations of a positive impact. Acupuncture with bee venom is one of the most popular complementary and alternative treatments for PD. Patient knowledge and attitudes towards these experimental treatments are unknown. Methods Using a 12-item questionnaire, a nationwide survey was conducted of 963 PD patients and 267 caregivers in 44 Korean Movement Disorders Society member hospitals from April 2013 to June 2013. The survey was performed by trained interviewers using conventional methods. Results Regarding questions on experimental treatments using stem cells or bee venom acupuncture, 5.1–17.7% of PD patients answered questions on safety, efficacy, and evidence-based practice incorrectly; however, more than half responded that they did not know the correct answer. Although safety and efficacy have not been established, 55.5% of PD patients responded that they were willing to receive stem cell treatment. With regard to participating in experimental treatments, there was a strong correlation between stem cell treatment and bee venom acupuncture (p < 0.0001, odds ratio = 5.226, 95% confidence interval 3.919–6.969). Younger age, higher education, and a longer duration of PD were all associated with a correct understanding of experimental treatments. Conclusions Our data suggest that relatively few PD patients correctly understand the safety and efficacy of experimental treatments and that PD patients are greatly interested in new treatments. We hope that our data will be used to educate or to plan educational programs for PD patients and caregivers.
Citations
Citations to this article as recorded by
Knowledge, Attitude, and Practice of Bee Venom Acupuncture Therapy on Rheumatoid Arthritis Among Patients in Saudi Arabia Shahd E Sharaf, Safaa Alsanosi, Abdullah R Alzahrani, Saeed S Al-Ghamdi, Sharaf E Sharaf, Nahla Ayoub International Journal of General Medicine.2022; Volume 15: 1171. CrossRef
Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease Patrick Bodilly Kane, Daniel M. Benjamin, Roger A. Barker, Anthony E. Lang, Todd Sherer, Jonathan Kimmelman Movement Disorders.2021; 36(1): 171. CrossRef
A Scoping Review of Patient and Public Perspectives on Cell and Gene Therapies Karen Macpherson, Olalekan Lee Aiyegbusi, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip Newsome, Melanie Calvert Regenerative Medicine.2021; 16(11): 1005. CrossRef
Patient and public perspectives on cell and gene therapies: a systematic review Olalekan Lee Aiyegbusi, Karen Macpherson, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip N. Newsome, Melanie J. Calvert Nature Communications.2020;[Epub] CrossRef
Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients Onanong Jitkritsadakul, Nonglak Boonrod, Roongroj Bhidayasiri Journal of the Neurological Sciences.2017; 374: 69. CrossRef
Attitudes to Stem Cell Therapy Among Ischemic Stroke Survivors in the Lund Stroke Recovery Study Joseph Aked, Hossein Delavaran, Olle Lindvall, Bo Norrving, Zaal Kokaia, Arne Lindgren Stem Cells and Development.2017; 26(8): 566. CrossRef
Professional ethics in complementary and alternative medicines in management of Parkinson’s disease Hee Jin Kim, Beomseok Jeon, Sun Ju Chung Journal of Parkinson’s Disease.2016; 6(4): 675. CrossRef